- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Early Intervention in Bipolar Disorder
During this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder.
Objectives:
- Describe the implications of early versus later intervention in bipolar disorder
- Explore suitable treatment options in bipolar disorder
Featuring
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreJoseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico
MoreDr. Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico’s Department of Psychiatry and Behavioral Sciences. With more than 350 publications and 20,000 scientific citations to his name, Dr. Tohen received in 2016 the Mogens Schou Award for Education and Teaching from the International Society for Bipolar Disorders. In 2017, Dr. Tohen was recognized as one of the world’s leading experts on bipolar disorder based on the breadth and depth of his publications. He earned his medical degree from the National University of Mexico and his Doctorate in Public Health (Epidemiology) from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, where he additionally obtained a DPsych (Diploma) in Psychiatric Research, and a fellowship at McLean Hospital, Harvard Medical School in Psychopharmacology. Dr. Tohen also obtained an MBA degree from the Indiana University Kelly School of Business.Jason Carter, PharmD (OPDC)
Senior Medical Science Liaison, Neuroscience Field Medical Affairs
Speakers Dr. Joseph Goldberg and Dr. Mauricio Tohen are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jason Carter, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
-
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
November 13 12:00 pm to 1:00 pm -
Post-Traumatic Stress Disorder (PTSD): Clinical Considerations & Unmet Needs
November 15 12:00 pm to 1:00 pm
Registration
Related Resources
-
Introduction to PTSD
Infographic November 11, 2024This infographic aims to raise awareness of PTSD in a straightforward manner appropriate for both individuals with lived experience, and health care providers.
-
Factors in Designing & Evaluating Clinical Trials for App-Based Interventions
On-Demand Webinar November 4, 2024In this webinar, Dr. Sara Morimoto, PsyD will share her expertise in developing and testing app-based mental health interventions.
-
Talking Points (Part III): Primary Care on Agitation – David Lewis
Podcast November 4, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Agitation associated with Alzheimer’s Dementia (AAD). In Part III…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: